News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PAUL STEVEN M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 2,395 options to buy
@ $39.16, valued at
$93.8k
|
|
| 11/30/2022 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Acquired 5 shares
@ $38.1675, valued at
$190.8 |
|
| 06/17/2022 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 9,947 options to buy
@ $31.36, valued at
$311.9k
|
|
| 04/05/2022 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 253 shares
@ $166.04, valued at
$42k
Sold 4,948 shares
@ $168.95, valued at
$836k
Sold 4,872 shares
@ $169.71, valued at
$826.8k
Sold 1,235 shares
@ $171.16, valued at
$211.4k
Sold 1,434 shares
@ $172.1, valued at
$246.8k
Sold 642 shares
@ $173.06, valued at
$111.1k
Sold 90 shares
@ $174.33, valued at
$15.7k
Sold 526 shares
@ $176.51, valued at
$92.8k
Sold 825 shares
@ $177.58, valued at
$146.5k
Sold 175 shares
@ $178.6, valued at
$31.3k
Exercised 15,000 options to buy
@ $11.33, valued at
$170k
|
|
| 02/17/2022 |
4
| PAUL STEVEN M (President & CEO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 146,900 options to buy
@ $111.97, valued at
$16.4M
|
|
| 01/05/2022 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 1,638 options to buy
@ $42.21, valued at
$69.1k
|
|
| 11/12/2021 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Acquired 1 shares
@ $43.36, valued at
$43.4 |
|
| 08/18/2021 |
4
| PAUL STEVEN M (PRESIDENT & CEO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Bought 1,183 shares
@ $105.63, valued at
$125k
Bought 1,181 shares
@ $106.1, valued at
$125.3k
|
|
| 07/19/2021 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $4.23, valued at
$63.5k
|
|
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 15,000 shares
@ $140, valued at
$2.1M
Exercised 15,000 options to buy
@ $9.3, valued at
$139.5k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $36.47, valued at
$364.7k
|
|
| 06/05/2020 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $11.79, valued at
$176.9k
|
|
| 02/19/2020 |
4
| PAUL STEVEN M (President & CEO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 140,000 options to buy
@ $99.72, valued at
$14M
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
| 07/01/2019 |
4
| PAUL STEVEN M (President & CEO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Bought 6,800 shares
@ $22.86, valued at
$155.4k
Bought 3,200 shares
@ $23.43, valued at
$75k
Granted 616,703 options to buy
@ $16, valued at
$9.9M
Granted 71,121 options to buy
@ $20.02, valued at
$1.4M
|
|
| 06/17/2019 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $24.68, valued at
$370.2k
|
|
| 06/06/2019 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $177.41, valued at
$1.8M
|
|
| 03/22/2019 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 2,993 shares
@ $161.04, valued at
$482k
Sold 2,919 shares
@ $161.05, valued at
$470.1k
Sold 1,967 shares
@ $161.02, valued at
$316.7k
|
|
| 03/20/2019 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 900 shares
@ $161.01, valued at
$144.9k
Sold 1,200 shares
@ $161.14, valued at
$193.4k
Sold 800 shares
@ $161.02, valued at
$128.8k
Sold 875 shares
@ $161.01, valued at
$140.9k
Sold 14,321 shares
@ $161.32, valued at
$2.3M
Sold 16,182 shares
@ $161.2, valued at
$2.6M
Sold 13,096 shares
@ $161.32, valued at
$2.1M
Sold 13,047 shares
@ $161.35, valued at
$2.1M
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
| 06/08/2018 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $154.06, valued at
$1.5M
|
|
| 03/09/2018 |
4
| PAUL STEVEN M (CEO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $28.72, valued at
$3.2M
|
|
| 03/08/2018 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 58,139 shares
@ $172, valued at
$10M
|
|
| 06/08/2017 |
4
| PAUL STEVEN M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $72.74, valued at
$1M
|
|
|
|
|